← Back to Patent Explorer
US4085215A Expired / Lapsed US ⏱️ 0.0 years remaining

Certain 5,6,7,8-tetrahydroquinoline-8-thiocarboxamides

Assignee: John Wyeth and Brother Ltd
•
Filing: 1975-07-30
•
Granted: 1978-04-18
•
Expires: 1995-07-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to novel pyridine derivatives which have a fused 5,6, or 7-membered saturated hydrocarbon ring adjacent to the nitrogen of the pyridine ring, and a group X situated on said hydrocarbon ring and separated by one carbon atom from the pyridine nitrogen atom, said group X is cyano, CONHR 3 , CSNHR 3 or CO 2 R 5 wherein R 3 is selected from hydrogen, lower alkyl and lower aralkyl radicals and R 5 is selected from hydrogen, lower alkyl and lower aralkyl radicals which may be substituted by alkyl, alkoxy, halogen, nitro or trifluoromethyl; other substituents may be present. Compounds wherein X is CSNHR 3 are anti-ulcer agents and the other compounds are intermediates therefor.

Inventors

  • 👤 Adrian Charles Ward Curran
  • 👤 Roger Crossley
  • 👤 David George Hill

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 23:19
CPC Classifications
C; C07; C07D; C07D215/00; C07D215/02; C07D215/04; C07C; C07C45/00; C07C45/61; C07C45/67; C07C45/68; C07C45/72; C07C45/73; C07D215/16; C07D215/20; C07D215/48; C07D219/00; C07D219/02; C07D219/04; C07D221/00; C07D221/02; C07D221/04; C07D221/06; C07D221/16; C07F; C07F3/00; C07F3/003

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 255 words
A compound of the formula ##STR12## or a acid addition salt thereof with a pharmaceutically acceptable acid, wherein R 1 , R 2 and R 6 are the same or different and are selected from hydrogen, trifluoromethyl, alkyl having from 1 to 6 carbon atoms, phenylalkyl wherein the alkyl group has 1 to 6 carbon atoms, or phenyl groups or R 1 and R 2 taken together represent a polymethylene chain of 3 to 5 carbon atoms, R 7 represents hydrogen or from 1 to 3 groups selected from alkyl of 1 to 6 carbon atoms (which may be substituted by alkoxy of 1 to 6 carbon atoms or trifluoromethyl), phenylalkyl wherein the alkyl group has 1 to 6 carbon atoms and phenyl groups, R 3 is hydrogen or alkyl of 1 to 6 carbon atoms, and any of the phenyl or the phenyl portion of any phenylalkyl groups R 1 , R 2 , R 6 and R 7 may be substituted by alkyl of 1 to 6 carbon atoms, lower alkoxy of 1 to 6 carbon atoms, halogen, nitro or trifluoromethyl with the provisos that (1) when R 1 and R 2 or R 2 and R 6 are both alkyl they are selected from normal and secondary alkyl groups and (2) when two alkyl R 7 groups are present on the same carbon atom then they are both n-alkyl groups and when two R 7 alkyl groups are present on adjacent carbon atoms they are selected from normal and secondary alkyl groups.
Claim 2
Dependent Claim 255 words
A compound of the formula ##STR12## or a acid addition salt thereof with a pharmaceutically acceptable acid, wherein R 1 , R 2 and R 6 are the same or different and are selected from hydrogen, trifluoromethyl, alkyl having from 1 to 6 carbon atoms, phenylalkyl wherein the alkyl group has 1 to 6 carbon atoms, or phenyl groups or R 1 and R 2 taken together represent a polymethylene chain of 3 to 5 carbon atoms, R 7 represents hydrogen or from 1 to 3 groups selected from alkyl of 1 to 6 carbon atoms (which may be substituted by alkoxy of 1 to 6 carbon atoms or trifluoromethyl), phenylalkyl wherein the alkyl group has 1 to 6 carbon atoms and phenyl groups, R 3 is hydrogen or alkyl of 1 to 6 carbon atoms, and any of the phenyl or the phenyl portion of any phenylalkyl groups R 1 , R 2 , R 6 and R 7 may be substituted by alkyl of 1 to 6 carbon atoms, lower alkoxy of 1 to 6 carbon atoms, halogen, nitro or trifluoromethyl with the provisos that (1) when R 1 and R 2 or R 2 and R 6 are both alkyl they are selected from normal and secondary alkyl groups and (2) when two alkyl R 7 groups are present on the same carbon atom then they are both n-alkyl groups and when two R 7 alkyl groups are present on adjacent carbon atoms they are selected from normal and secondary alkyl groups.
Claim 3
Dependent Claim 56 words
A compound as claimed in claim 1, or an acid addition salt thereof with a pharmaceutically acceptable acid wherein R 1 , R 2 , R 6 and R 7 are the same or different and are selected from hydrogen and lower alkyl of 1 to 4 carbon atoms, and R 3 is hydrogen or methyl.
Claim 4
Dependent Claim 25 words
A compound as claimed in claim 1 wherein R 1 , R 2 , R 3 and R 6 are selected from hydrogen and methyl.
Claim 5
Dependent Claim 27 words
A compound as claimed in claim 1, wherein R 1 , R 2 and R 6 are selected from hydrogen and t-butyl and R 3 is hydrogen.
Claim 6
Dependent Claim 10 words
A compound as claimed in claim 1, which is 3,4-dimethyl-5,6,7,8-tetrahydroquinoline-8-thiocarboxamide.
Claim 7
Dependent Claim 10 words
A compound as claimed in claim 2, which is 2-methyl-5,6,7,8-tetrahydroquinoline-8-thiocarboxamide.
Claim 8
Dependent Claim 20 words
A compound as claimed in claim 2, which is selected from 3-methyl-5,6,7,8-tetrahydroquinoline-8-thiocarboxamide and the pharmaceutically acceptable acid addition salts thereof.
Claim 9
Dependent Claim 10 words
A compound as claimed in claim 2, which is 4-methyl-5,6,7,8-tetrahydroquinoline-8-thiocarboxamide.
Claim 10
Dependent Claim 10 words
A compound as claimed in claim 2, which is 3-methyl-5,6,7,8-tetrahydroquinoline-8-(N-methyl)-thiocarboxamide.
Claim 11
Dependent Claim 10 words
A compound as claimed in claim 3, which is 2-t-butyl-5,6,7,8-tetrahydroquinoline-8-thiocarboxamide.
Claim 12
Dependent Claim 10 words
A compound as claimed in claim 1, which is 2-phenyl-5,6,7,8-tetrahydroquinoline-8-thiocarboxamide.
Claim 13
Dependent Claim 81 words
A compound as claimed in claim 1, which is 5,6,7,8-tetrahydroquinoline-8-thiocarboxamide (having the following nmr spectrum in d 6 DMSO (100MH z ): ______________________________________ δ1.5- 2.3 broad multiplet 4 protons CH.sub.2 -6 and 7 δ2.7 multiplet 2 protons CH.sub.2 -5 δ4.15 triplet (j=7Hz) 1 proton CH-8 δ7.08 quartet 1 proton H-3 δ7.44 quartet 1 proton H-4 δ8.29 quartet 1 proton H-2 δ9.25 and 9.45 broad doublet 2 protons NH.sub.2 Coupling constants = J.sub.23 = 5Hz, J.sub.24 = 1.5Hz, J.sub.34 = ______________________________________ 8Hz.
Claim 14
Dependent Claim 18 words
A compound as claimed in claim 1, which is 3,6-dimethyl-5,6,7,8-tetrahydroquinoline-8-thiocarboxamide or a pharmaceutically acceptable acid addition salt thereof.
Claim 15
Dependent Claim 18 words
A compound as claimed in claim 1, which is 3,5-dimethyl-5,6,7,8-tetrahydroquinoline-8-thiocarboxamide or a pharmaceutically acceptable acid addition salt thereof.
Claim 16
Dependent Claim 28 words
A pharmaceutical composition for treating ulcers comprising an effective amount of a compound as claimed in claim 1 and pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier.
Claim 17
Dependent Claim 12 words
A pharmaceutical composition as claimed in claim 15, in unit dosage form.
Claim 18
Independent Claim 271 words
A method of treating ulcers in an afflicted host which method comprises administering to said host a compound of the formula ##STR13## or a acid addition salt thereof with a pharmaceutically acceptable acid, wherein R 1 , R 2 and R 6 are the same or different and are selected from hydrogen, trifluoromethyl, alkyl having from 1 to 6 carbon atoms, phenylalkyl wherein the alkyl group has 1 to 6 carbon atoms, or phenyl groups, or R 1 and R 2 taken together represent a polymethylene chain of 3 to 5 carbon atoms, R 7 represents hydrogen or from 1 to 3 groups selected from alkyl of 1 to 6 carbon atoms (which may be substituted by alkoxy of 1 to 5 carbon atoms or trifluoromethyl), phenylalkyl wherein the alkyl group has 1 to 6 carbon atoms and phenyl groups, R 3 is hydrogen or alkyl of 1 to 6 carbon atoms, and any of the phenyl or the phenyl portion of any phenylalkyl groups R 1 , R 2 , R 6 and R 7 may be substituted by alkyl of 1 to 6 carbon atoms, lower alkoxy of 1 to 6 carbon atoms, halogen, nitro or trifluoromethyl with the provisos that (1) when R 1 and R 2 or R 2 and R 6 are both alkyl they are selected from normal and secondary alkyl groups and (2) when two alkyl R 7 groups are present on the same carbon atom then they are both n-alkyl groups and when two R 7 alkyl groups are present on adjacent carbon atoms they are selected from normal and secondary alkyl groups.
Claim 19
Independent Claim 271 words
A method of treating ulcers in an afflicted host which method comprises administering to said host a compound of the formula ##STR13## or a acid addition salt thereof with a pharmaceutically acceptable acid, wherein R 1 , R 2 and R 6 are the same or different and are selected from hydrogen, trifluoromethyl, alkyl having from 1 to 6 carbon atoms, phenylalkyl wherein the alkyl group has 1 to 6 carbon atoms, or phenyl groups, or R 1 and R 2 taken together represent a polymethylene chain of 3 to 5 carbon atoms, R 7 represents hydrogen or from 1 to 3 groups selected from alkyl of 1 to 6 carbon atoms (which may be substituted by alkoxy of 1 to 5 carbon atoms or trifluoromethyl), phenylalkyl wherein the alkyl group has 1 to 6 carbon atoms and phenyl groups, R 3 is hydrogen or alkyl of 1 to 6 carbon atoms, and any of the phenyl or the phenyl portion of any phenylalkyl groups R 1 , R 2 , R 6 and R 7 may be substituted by alkyl of 1 to 6 carbon atoms, lower alkoxy of 1 to 6 carbon atoms, halogen, nitro or trifluoromethyl with the provisos that (1) when R 1 and R 2 or R 2 and R 6 are both alkyl they are selected from normal and secondary alkyl groups and (2) when two alkyl R 7 groups are present on the same carbon atom then they are both n-alkyl groups and when two R 7 alkyl groups are present on adjacent carbon atoms they are selected from normal and secondary alkyl groups.
Claim 20
Dependent Claim 10 words
A compound as claimed in claim 1 which is 5,6,7,8-tetrahydroquinoline-8-(N-methyl)thiocarboxamide.

References Cited (Backward Citations)

US4009169A Cited
US3963722A Cited
US4000142A Cited
US3991060A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-04-17 1981-10-17 1982-04-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-04-17 1985-10-17 1986-04-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-04-17 1989-10-17 1990-04-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag